Investor Alerts Required fields denoted by an asterisk (). Alert type Quote SEC Filing Event News Email IR Side Nav Overview Press Releases Events & Presentations Corporate Governance Stock Information Financials Overview Annual Reports (20-F) Annual Reports GER Quarterly Reports SEC Filings Analyst Coverage Shareholder Services Investor FAQs Information Request Sign-up for Email Alerts Toolkit Annual General Meeting Information Requests Corporate Presentation Sign up for Email Alerts RSS Feeds Media Contact Michael Boehler, MD Head of Global External CommunicationsMedia@biontech.de +49 6131 9084-1640 Investor Contact Sylke Maas, Ph.D. VP Investor Relations & Business StrategyInvestors@biontech.de +49 6131 9084-1074 For U.S. Investors: Westwicke Victoria Meissner, M.D. +1 646-677-1837 Whistleblower Hotline BioNTech Hotline (anonymous) Germany: 0800 000 8972 US: 844 901 0271 Other: +1 757 278 0107 Online Access to Whistle Blowing Reporting Or by Email
Investor Alerts Required fields denoted by an asterisk (). Alert type Quote SEC Filing Event News Email
